Zuo, Mengxuan
Cao, Yuzhe
Yang, Yi
Zheng, Guanglei
Li, Da
Shao, Hongyan
Ma, Qiaoyun
Song, Peng
An, Chao
Li, Wang http://orcid.org/0000-0002-4293-8182
Clinical trials referenced in this document:
Documents that mention this clinical trial
Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma
https://doi.org/10.1007/s12072-024-10690-6
Article History
Received: 21 February 2024
Accepted: 21 April 2024
First Online: 3 July 2024
Declarations
:
: The authors have no conflicts of interest to declare.
: Informed consent was waived due to the retrospective nature of the analysis. The protocol of this study (SL-B2023-411-02) was reviewed and approved by the Sun Yat-sen University Cancer Center Ethics Committee (Approval Number: B2023-411-01).